Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.51
(-2.13%)
CNY 5.51
(-2.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 99.74 Million CNY | -33.06% |
| 2022 | 136.4 Million CNY | -9.69% |
| 2021 | 169.74 Million CNY | 7.39% |
| 2020 | 170.84 Million CNY | 38.85% |
| 2019 | 105.81 Million CNY | -5.13% |
| 2018 | 113.24 Million CNY | -9.9% |
| 2017 | 124.97 Million CNY | 23.29% |
| 2016 | 100.97 Million CNY | 4.05% |
| 2015 | 93.62 Million CNY | 36.17% |
| 2014 | 72.35 Million CNY | 29.19% |
| 2013 | 54.33 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.13 Million CNY | 52.76% |
| 2024 Q3 | 25.92 Million CNY | 180.73% |
| 2024 Q2 | -32.11 Million CNY | -335.68% |
| 2023 Q3 | 36.5 Million CNY | 668.79% |
| 2023 Q4 | -15.64 Million CNY | -142.86% |
| 2023 FY | - CNY | -33.06% |
| 2023 Q1 | 18.79 Million CNY | 347.89% |
| 2023 Q2 | -6.41 Million CNY | -134.15% |
| 2022 Q3 | 65.72 Million CNY | 1347.79% |
| 2022 Q1 | 24.67 Million CNY | 51.68% |
| 2022 FY | - CNY | -9.69% |
| 2022 Q4 | -7.58 Million CNY | -111.53% |
| 2022 Q2 | 4.53 Million CNY | -81.6% |
| 2021 FY | - CNY | 7.39% |
| 2021 Q4 | 16.26 Million CNY | -71.03% |
| 2021 Q1 | 31.73 Million CNY | 286.1% |
| 2021 Q2 | 12.03 Million CNY | -62.08% |
| 2021 Q3 | 56.14 Million CNY | 366.48% |
| 2020 Q4 | -17.05 Million CNY | -119.82% |
| 2020 FY | - CNY | 38.85% |
| 2020 Q3 | 86.01 Million CNY | 731.2% |
| 2020 Q2 | 10.34 Million CNY | -78.8% |
| 2020 Q1 | 48.81 Million CNY | 666.73% |
| 2019 Q1 | 39.88 Million CNY | 515.32% |
| 2019 Q4 | 6.36 Million CNY | -85.48% |
| 2019 Q2 | 2.17 Million CNY | -94.54% |
| 2019 Q3 | 43.83 Million CNY | 1911.45% |
| 2019 FY | - CNY | -5.13% |
| 2018 Q4 | 6.48 Million CNY | 0.0% |
| 2018 FY | - CNY | -9.9% |
| 2018 Q1 | 109.31 Million CNY | 0.0% |
| 2017 Q2 | 29.54 Million CNY | 0.0% |
| 2017 Q1 | 29.54 Million CNY | 38.76% |
| 2017 FY | - CNY | 23.29% |
| 2016 Q1 | 26.9 Million CNY | 0.0% |
| 2016 Q3 | 21.29 Million CNY | -20.87% |
| 2016 Q2 | 26.9 Million CNY | 0.0% |
| 2016 Q4 | 21.29 Million CNY | 0.0% |
| 2016 FY | - CNY | 4.05% |
| 2015 FY | - CNY | 36.17% |
| 2014 FY | - CNY | 29.19% |
| 2013 FY | - CNY | 0.0% |